FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

704256006: Vedolizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3011048012 Vedolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3011945013 Vedolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726961000052115 vedolizumab sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vedolizumab Is a monoklonalt antikroppsagens false Inferred relationship Some
Vedolizumab Is a Alpha-4 integrin receptor antagonist true Inferred relationship Some
Vedolizumab Is a Monoclonal antibody true Inferred relationship Some
Vedolizumab Has disposition (attribute) Alpha-4 integrin receptor antagonist (disposition) true Inferred relationship Some
Vedolizumab Has disposition (attribute) Immunomodulator (disposition) true Inferred relationship Some
Vedolizumab Is a murin-human monoklonal IgG-antikropp false Inferred relationship Some
Vedolizumab Is a Immunosuppressant (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Vedolizumab Inferred relationship Some
Product containing vedolizumab (medicinal product) Has active ingredient True Vedolizumab Inferred relationship Some 1
Product containing only vedolizumab (medicinal product) Has active ingredient True Vedolizumab Inferred relationship Some 1
Vedolizumab therapy (procedure) Direct substance True Vedolizumab Inferred relationship Some 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Vedolizumab Inferred relationship Some 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Vedolizumab Inferred relationship Some 1
Vedolizumab-containing product in parenteral dose form Has active ingredient True Vedolizumab Inferred relationship Some 1
Product containing only vedolizumab in parenteral dose form (medicinal product form) Has active ingredient True Vedolizumab Inferred relationship Some 1
Vedolizumab 158.824 mg/mL solution for injection Has precise active ingredient True Vedolizumab Inferred relationship Some 1
Vedolizumab 158.824 mg/mL solution for injection Has basis of strength substance (attribute) True Vedolizumab Inferred relationship Some 1
Vedolizumab 300 mg powder for solution for infusion vial Has precise active ingredient True Vedolizumab Inferred relationship Some 1
Vedolizumab 300 mg powder for solution for infusion vial Has basis of strength substance (attribute) True Vedolizumab Inferred relationship Some 1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial Has precise active ingredient True Vedolizumab Inferred relationship Some 1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial Has basis of strength substance (attribute) True Vedolizumab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start